# Advil **Source:** https://geo.sig.ai/brands/advil **Vertical:** Healthcare **Subcategory:** General **Tier:** Emerging **Website:** advil.com **Last Updated:** 2026-04-14 ## Summary Global #1 OTC ibuprofen brand owned by Haleon (LSE/NYSE: HLN, GSK 2022 spinoff); Pfizer exited $3B+ stake early 2025 with ADA Seal for Advil Dual Action dental pain competing with Tylenol and Aleve for OTC analgesic market. ## Company Overview Advil is a global over-the-counter ibuprofen pain relief brand — owned by Haleon plc (LSE: HLN / NYSE: HLN), the consumer healthcare company spun off from GSK on July 18, 2022, with Pfizer completing its full stake exit in early 2025 for $3+ billion — providing consumers with 23+ ibuprofen-based product varieties for pain, headache, cold, and sleep management including Advil Extra Strength, Advil Rapid Release Gels, Advil PM, Advil Dual Action (ibuprofen + acetaminophen), and Children's Advil. Advil entered the US market in 1984 (the first OTC ibuprofen in America, considered the "most famous prescription-to-OTC switch in history") and generates approximately $800 million+ annually as one of Haleon's flagship brands alongside Sensodyne, Panadol, Centrum, and Theraflu. In September 2024, Advil Dual Action became the first OTC pain reliever to earn the American Dental Association (ADA) Seal of Acceptance for temporary management of acute dental pain. Advil's ibuprofen formulation addresses the inflammation-driven pain and fever that makes it the preferred OTC analgesic for musculoskeletal pain, dental pain, menstrual cramps, and fever: ibuprofen's mechanism of action (inhibiting prostaglandin synthesis via COX-1 and COX-2 inhibition) addresses the inflammation component of pain more effectively than acetaminophen for conditions with an inflammatory etiology — making Advil the recommended OTC option for arthritis, muscle injury, headache with tension component, and post-procedure dental pain where inflammation drives the symptom. Advil Dual Action's combination (ibuprofen + acetaminophen) provides complementary pain pathways coverage that clinical studies demonstrate superior efficacy to either agent alone — the mechanism behind the ADA Seal for dental pain management. In 2025, Advil (Haleon) competes in the OTC analgesic, ibuprofen pain relief, and consumer healthcare market with Tylenol (Kenvue/Kimberly-Clark pending, acetaminophen #1 recommendation), Aleve (Bayer, naproxen sodium), and Motrin IB (Johnson & Johnson/Kenvue) for pharmacist recommendation, retail shelf positioning, and consumer OTC pain relief purchasing. Haleon's standalone strategy (post-GSK spinoff and post-Pfizer exit) focuses Advil investment on brand building, formulation innovation, and international market expansion — without the capital allocation competition from GSK's pharmaceutical pipeline or Pfizer's priorities. The ADA Seal for dental pain (a first in the OTC category) provides a differentiated clinical claim for the dental pain management segment. The 2025 strategy under Haleon CEO Brian McNamara focuses on digital health integration (Advil companion apps for pain tracking), growing Advil PM and Advil Dual Action penetration, and defending shelf position against private label ibuprofen share gains at major retailers. ## Frequently Asked Questions ### What is Advil? Advil is a brand of pain-relieving medication owned by Haleon. The primary active ingredient is ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID) used for temporary relief of minor aches, pains, and fever. ### Who owns Advil? Advil is currently owned by Haleon, a consumer healthcare company spun off from GSK in July 2022. Previously, the brand was owned by Wyeth (acquired by Pfizer in 2009) and before that by American Home Products. ### When was Advil founded? Advil first entered the American market in 1984 through Whitehall (a division of Wyeth), when ibuprofen gained FDA approval for over-the-counter sales. ### How many Advil products are there? As of 2024, there were 23 varieties of Advil available on the U.S. market, including Extra Strength, Rapid Release Gels, Dual Action, PM formulations, Liqui-Gels, and Children's products. ### What is Advil Dual Action? Advil Dual Action combines ibuprofen and acetaminophen and is the first over-the-counter pain reliever to earn the American Dental Association Seal of Acceptance for safe and effective temporary management of acute dental pain. ### Is Advil safe? When used as directed, Advil is considered safe for most adults and children over a certain age. However, as an NSAID, it should be used with caution by those with certain medical conditions. Always follow label directions. ### What is the difference between Advil and Tylenol? Advil contains ibuprofen, an NSAID that reduces inflammation, while Tylenol contains acetaminophen, which works differently to relieve pain and reduce fever. Each has different safety considerations and uses. ### What is Haleon? Haleon is a global consumer healthcare company established in July 2022 as a spin-off from GSK. It owns major brands including Advil, Sensodyne, Centrum, Panadol, and Theraflu. ### What is Advil's market position? Advil is America's #1 selling ibuprofen brand and one of the leading OTC pain relief products globally, recognized for its innovation in pain relief formulations. ### What are Advil's future plans? Under Haleon ownership, Advil continues to innovate with new formulations and delivery systems while expanding its clinical validation, as demonstrated by earning the ADA Seal of Acceptance. ## Tags b2c, healthtech, north-america --- *Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*